dCas9 Targeted Proteome Profiling Reveals p300‐Mediated Reciprocal Regulation of SMAD and SP1 as a Driver of GM2‐synthase Transcription in Renal Cell Carcinoma
The FASEB Journal · 2026
DOI: 10.1096/fj.202502746r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Sounak Banerjee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Bose Institute, Kolkata, West Bengal, India. Hauptthemen laut MEDLINE: Sp1 Transcription Factor, E1A-Associated p300 Protein, Gene Expression Regulation, Neoplastic, Kidney Neoplasms. Die Arbeit nennt 63 Literaturangaben. Gefördert von: MOHFW | DHR | Indian Council of Medical Research (ICMR), Department of Science and Technology, Ministry of Science and Technology, India (DST), Indian Council of Medical Research.
Abstract (Originalsprache)
Glycolipids constitute an important component of the plasma membrane based on both abundance as well as function. Gangliosides, being a class of structurally diverse and functionally varied glycolipids, can act both as a receptor as well as a ligand and therefore are established as a crucial player in several normal cellular processes. In certain diseases, and in particular cancer, select gangliosides are over‐expressed often leading to disease manifestation. GM2‐synthase , the enzyme responsible for the formation of a pro‐tumorigenic ganglioside, GM2, is well reported to be over‐expressed across various cancer tissues and cell lines. This over‐expression of GM2‐synthase has been linked with increased migration, invasion, and epithelial to mesenchymal transition (1) as well as induction of a local and systemic host immune suppression in cancer. Despite only a handful of studies demonstrating an epigenetic regulation underlying the transcriptional regulation of the GM2‐synthase (B4GalNT1) gene, the detailed mechanism still remains unclear. Here we identified the total proteome associated with the GM2‐synthase promoter through a two‐step CRISPR‐dCas9 based proteome profiling approach by categorizing all the identified proteins leading to a detailed elucidation of the molecular drivers behind GM2‐synthase transcription. While the previous study identified an acetylation‐dependent de‐repression of the transcription factor SP1 causing GM2‐synthase activation, the underlying molecular mechanism driving its activation wasn't clear. This study demonstrated that the histone acetyl transferase p300, acts as a pivotal factor which on one hand causes acetylation‐mediated degradation of SP1, and on the other hand activates SMAD2/4 to have a direct positive impact on GM2‐synthase gene transcription. We identified p300 to have an activator role in GM2‐synthase gene transcription through knock out, knock down, and over‐expression experiments. Furthermore, SP1 degradation, SMAD activation, and their DNA binding patterns show the reciprocal role of p300 on SP1 and SMAD complexes. Altogether we have identified SMAD2/4 as an activator complex, p300 as a positive regulator, and uncovered a critical p300‐SMAD‐SP1 regulatory axis in GM2‐synthase transcriptional regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Bose Institute, Kolkata, West Bengal, India.
- Department of Zoology, Ramakrishna Mission Vidyamandira, Belur Math, Howrah, India.
- Proteomics and Metabolomics SLR, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID-Profile: Kaushik Biswas
Förderung
- MOHFW | DHR | Indian Council of Medical Research (ICMR)
- Department of Science and Technology, Ministry of Science and Technology, India (DST)
- Indian Council of Medical Research
Zitieren
APA
Banerjee, S., Banerjee, A., Ray, S., Ray, A., Paul, D., Dastidar, S. G., Willard, B., & Biswas, K. (2026). dCas9 Targeted Proteome Profiling Reveals p300‐Mediated Reciprocal Regulation of SMAD and SP1 as a Driver of GM2‐synthase Transcription in Renal Cell Carcinoma. The FASEB Journal. https://doi.org/10.1096/fj.202502746r
Vancouver
Banerjee S, Banerjee A, Ray S, Ray A, Paul D, Dastidar SG, et al. dCas9 Targeted Proteome Profiling Reveals p300‐Mediated Reciprocal Regulation of SMAD and SP1 as a Driver of GM2‐synthase Transcription in Renal Cell Carcinoma. The FASEB Journal. 2026. doi:10.1096/fj.202502746r
BibTeX
@article{Banerjee2026,
author = {Banerjee, Sounak and Banerjee, Avisek and Ray, Subha and Ray, Aishwarya and Paul, Debarati and Dastidar, Shubhra Ghosh and Willard, Belinda and Biswas, Kaushik},
title = {dCas9 Targeted Proteome Profiling Reveals p300‐Mediated Reciprocal Regulation of SMAD and SP1 as a Driver of GM2‐synthase Transcription in Renal Cell Carcinoma},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202502746r}
}
EUVIMED